NO20061287L - Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt - Google Patents

Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt

Info

Publication number
NO20061287L
NO20061287L NO20061287A NO20061287A NO20061287L NO 20061287 L NO20061287 L NO 20061287L NO 20061287 A NO20061287 A NO 20061287A NO 20061287 A NO20061287 A NO 20061287A NO 20061287 L NO20061287 L NO 20061287L
Authority
NO
Norway
Prior art keywords
myocarditis
treatment
chemokine
inhibiting
piperazine derivatives
Prior art date
Application number
NO20061287A
Other languages
English (en)
Norwegian (no)
Inventor
William P Dole
Hideki Futamatsu
Mitsuaki Isobe
Noritaka Koga
Jun-Ichi Suzuki
Original Assignee
Univ Tokyo Medical & Dental
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34216121&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061287(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Tokyo Medical & Dental filed Critical Univ Tokyo Medical & Dental
Publication of NO20061287L publication Critical patent/NO20061287L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20061287A 2003-08-22 2006-03-21 Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt NO20061287L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49738003P 2003-08-22 2003-08-22
PCT/US2004/027343 WO2005018642A1 (en) 2003-08-22 2004-08-20 Chemokine inhibiting piperazine derivatives and their use to treat myocarditis

Publications (1)

Publication Number Publication Date
NO20061287L true NO20061287L (no) 2006-05-18

Family

ID=34216121

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061287A NO20061287L (no) 2003-08-22 2006-03-21 Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt

Country Status (17)

Country Link
US (2) US20050043318A1 (es)
EP (1) EP1660089A1 (es)
JP (1) JP2007503397A (es)
CN (1) CN1838957A (es)
AR (1) AR046329A1 (es)
AU (1) AU2004266153A1 (es)
BR (1) BRPI0413846A (es)
CA (1) CA2534941A1 (es)
CR (1) CR8286A (es)
EC (1) ECSP066440A (es)
IL (1) IL173584A0 (es)
MX (1) MXPA06002053A (es)
NO (1) NO20061287L (es)
PE (1) PE20050871A1 (es)
RU (1) RU2006108865A (es)
WO (1) WO2005018642A1 (es)
ZA (1) ZA200602306B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006018024A2 (en) * 2004-08-18 2006-02-23 Ace Aps Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists
JP4324221B2 (ja) 2005-08-26 2009-09-02 株式会社医薬分子設計研究所 Ｐｐａｒアゴニスト活性を有する誘導体
MX368059B (es) 2013-07-18 2019-09-18 Novartis Ag Inhibidores de autotaxina que comprenden un núcleo de anillo heteroaromático de bencil-amida cíclica.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0634175T3 (da) * 1993-07-15 2001-04-30 Hoffmann La Roche Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist
US5631245A (en) * 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US20020052420A1 (en) * 1998-12-02 2002-05-02 George Hasko Method and composition for modulating an immune response
AU4796700A (en) * 1999-05-13 2000-12-05 Dupont Pharmaceuticals Research Laboratories, Inc. Ureido-substituted cyclic amine derivatives and their use as drug
CA2373607A1 (en) * 1999-05-14 2000-11-23 Bristol-Myers Squibb Pharma Research Labs, Inc. Cyclic amine derivatives and their uses
JP2001064202A (ja) * 1999-08-25 2001-03-13 Kissei Pharmaceut Co Ltd 心不全予防治療剤
US6740636B2 (en) * 2000-07-31 2004-05-25 Schering Aktiengesellschaft Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection

Also Published As

Publication number Publication date
EP1660089A1 (en) 2006-05-31
WO2005018642A1 (en) 2005-03-03
AU2004266153A1 (en) 2005-03-03
AR046329A1 (es) 2005-12-07
CA2534941A1 (en) 2005-03-03
RU2006108865A (ru) 2007-09-27
ECSP066440A (es) 2006-09-18
US20050043318A1 (en) 2005-02-24
CN1838957A (zh) 2006-09-27
PE20050871A1 (es) 2005-11-02
JP2007503397A (ja) 2007-02-22
ZA200602306B (en) 2009-08-26
US20080269247A1 (en) 2008-10-30
CR8286A (es) 2006-12-07
MXPA06002053A (es) 2006-08-11
BRPI0413846A (pt) 2006-10-24
IL173584A0 (en) 2006-07-05

Similar Documents

Publication Publication Date Title
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
TW200634012A (en) 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
NO20061157L (no) 4-pyramidonderivater og deres anvendelse som peptidylpeptidmeinbibitorer
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
NO20071915L (no) Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
DK1517890T3 (da) Kationisk substituerede diphenylazetidinoner, fremgangsmåde til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
DK1776349T3 (da) 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE)
AR028649A1 (es) Derivados de 4-(2-feniltiazol-5-il)-1,4-diazabiciclo [3.2.2]nonano, su preparacion y su aplicacion en terapéutica
MXPA05010875A (es) Derivados de piperazina como inhibidores de renina.
MXPA05011962A (es) Oxiarenos substituidos.
SE0303541D0 (sv) New compounds
NO20054340L (no) Nye sammenkoplede heterocykler og deres anvendelse
NO20054371L (no) Somatostatin-dopamin kimaere analoger
AR028647A1 (es) Derivados de 1,4-diazabiciclo[3.2.2]nonano benzoxazol, benzotiazol y bencimidazol, su preparacion y su aplicacion en terapéutica
NO20054494L (no) Peptidvektorer
ATE446753T1 (de) Verwendung von substituierten 2-thio-3,5-dicyano- 4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen
IS8521A (is) Þríhringlaga indólhýdróxýetýlamínafleiður og notkun þeirra í meðhöndlun á Alzheimerssjúkdómi
NO20081713L (no) Pyrimidinderivater og deres anvendelse som KCNQ-kaliumkanalapnere
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
NO20063944L (no) Piperidinylkarbonyl-pyrrolidiner og deres anvendelse som melanokortinagonister
NO20062453L (no) Tiozolidinoner, fremstilling og anvendelse derav som legemidler
NO20061287L (no) Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application